Error: Could not add to watchlist. X

Catalyst Biosciences Inc

+ Watchlist
TRGT:US
Ticker Change
TRGT:US has changed to a new ticker symbol
0.96
USD
5.76
85.71%
As of 20:10:00 ET on 08/20/2015.
Volume
202,093
Previous Close
6.72
Volume
202,093
Previous Close
6.72
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m USD)
10.961
Shares Outstanding (m)
11.417
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Catalyst Biosciences Inc. is a clinical-stage biopharmaceutical company focused on creating and developing novel medicines to address serious medical conditions. The Company focuses its product development efforts in the fields of hemostasis and delayed graft function, including treatment of hemophilia and surgical bleeding.
ADDRESS
200 East First Street
Suite 300
Winston-Salem, NC 27101
United States
PHONE
1-336-480-2100
  • Nassim Usman
    President/CEO
  • Fletcher Payne
    Chief Financial Officer
  • Edwin L Madison
    Chief Scientific Officer
Show More